Clinical implication of hormone treatment in postmenopausal kidney transplants.
Hung
C J
CJ
Department of Surgery, National Cheng Kung University, ROC.
Lee
P C
PC
Song
C M
CM
Chang
Y T
YT
Tsai
M T
MT
Dai
Y S
YS
Chen
E J
EJ
Lei
H Y
HY
Lee
P H
PH
Lee
C J
CJ
D000328:Adult; D000368:Aged; D015519:Bone Density; D002116:Calcitonin / Q000097:blood; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006728:Hormones / Q000097:blood*; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control*; D010281:Parathyroid Hormone / Q000097:blood; D017698:Postmenopause; D017697:Premenopause; D011374:Progesterone / Q000097:blood
D004967:Estrogens; D006728:Hormones; D010281:Parathyroid Hormone; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D002116:Calcitonin